Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the gross margin high or low?
The gross margin of 73.71% is 70% above its 5-year average of 43.48%, near the high end of its 5-year range (0.00%–97.01%).
118.56% above its 12-month average of 33.73%.
Reported quarterly gross margin; no daily interpolation. Q4 FY2025 (2025-12-31): 57.22%.
GROSS MARGIN
73.71%
GROSS MARGIN AVG TTM
33.73%
GROSS MARGIN AVG 3Y
43.58%
GROSS MARGIN AVG 5Y
43.48%
GROSS MARGIN AVG 10Y
27.20%
GROSS MARGIN AVG 15Y
13.62%
GROSS MARGIN AVG 20Y
7.63%
CURRENT VS TTM AVG
+118.56%
CURRENT VS 3Y AVG
+69.14%
CURRENT VS 5Y AVG
+69.54%
CURRENT VS 10Y AVG
+170.98%
CURRENT VS 15Y AVG
+441.36%
CURRENT VS 20Y AVG
+865.77%
SECTOR MEDIAN · HEALTHCARE
41.38%
median of 863 covered companies
CURRENT VS SECTOR MEDIAN
+78.13%
vs the sector median at left
Market Cap
$109358.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$380715.00
Gross Margin
61.90%
TTM Avg
-388.16%
3Y Avg
-189.98%
5Y Avg
-127.92%
Market Cap
$381940.00
Gross Margin
0.00%
TTM Avg
0.00%
3Y Avg
2.16%
5Y Avg
0.42%
Market Cap
$97282.00
Gross Margin
N/A
TTM Avg
0.00%
3Y Avg
0.00%
5Y Avg
0.00%
Market Cap
$71110.00
Gross Margin
-4864.71%
TTM Avg
-2432.36%
3Y Avg
-1195.54%
5Y Avg
-797.02%
Market Cap
$61495.00
Gross Margin
-60.46%
TTM Avg
-17.77%
3Y Avg
23.60%
5Y Avg
-269.73%
Market Cap
$30504.00
Gross Margin
-11.45%
TTM Avg
3.36%
3Y Avg
12.08%
5Y Avg
7.57%
| NAME | MARKET CAP | GROSS MARGIN | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| SciSparc Ltd. (SPRC) | $242924.00 | 73.71% | 33.73% | 43.58% | 43.48% |
| Silexion Therapeutics Ltd. (SLXN)vs › | $109358.00 | 0.00% | 0.00% | 0.00% | 0.00% |
| Virax Biolabs Group Limited (VRAX)vs › | $380715.00 | 61.90% | -388.16% | -189.98% | -127.92% |
| Niki BioSolutions, Inc. (NIKI)vs › | $381940.00 | 0.00% | 0.00% | 2.16% | 0.42% |
| Psyence Biomedical Ltd. (PBM)vs › | $97282.00 | N/A | 0.00% | 0.00% | 0.00% |
| PRF Technologies Ltd. (PRFX)vs › | $71110.00 | -4864.71% | -2432.36% | -1195.54% | -797.02% |
| Akanda Corp. (AKAN)vs › | $61495.00 | -60.46% | -17.77% | 23.60% | -269.73% |
| Zhongchao Inc. (ZCMD)vs › | $31778.00 | 42.47% | 49.33% | 46.84% | 51.88% |
| Mobile-health Network Solutions Class A Ordinary Shares (MNDR)vs › | $30504.00 | -11.45% | 3.36% | 12.08% | 7.57% |
| NewGenIvf Group Limited (NIVF)vs › | $6128.00 | N/A | 26.93% | 28.12% | 27.47% |
Gross Margin
73.7%
(Revenue - COGS) / Revenue
Gross Margin = Gross Profit / Revenue
Gross margin is the percentage of revenue remaining after the cost of goods sold, reflecting core product profitability.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | GROSS MARGIN |
|---|---|
| 2025-12-31 | 57.22% |
| 2025-06-30 | 37.09% |
| 2024-12-31 | 6.87% |
| 2024-06-30 | 56.43% |
| 2023-12-31 | 35.61% |
| 2023-06-30 | 35.75% |
| 2022-12-31 | 76.10% |
| 2022-06-30 | 0.00% |
| 2021-12-31 | 97.01% |
| 2021-06-30 | 0.00% |
| 2020-12-31 | 76.18% |
| 2020-06-30 | 0.00% |
| 2019-12-31 | 92.97% |
| 2019-06-30 | 0.00% |
| 2018-12-31 | 0.00% |
| 2018-06-30 | 0.00% |
| 2017-12-31 | 0.00% |
| 2017-06-30 | 0.00% |
| 2016-12-31 | 0.00% |
| 2016-06-30 | 0.00% |
| 2015-12-31 | 0.00% |
| 2015-06-30 | 0.00% |
| 2014-12-31 | 0.00% |
| 2014-06-30 | 0.00% |
| 2013-12-31 | 0.00% |
| 2013-06-30 | 0.00% |
| 2012-12-31 | 0.00% |
| 2012-06-30 | 0.00% |
| 2011-12-31 | 0.00% |
| 2010-12-31 | 0.00% |
| 2009-12-31 | 0.00% |
| 2008-12-31 | 0.00% |
| 2007-12-31 | 0.00% |
| 2006-12-31 | 0.00% |
